Literature DB >> 25976505

The predicting value of postoperative body temperature on long-term survival in patients with rectal cancer.

Huichuan Yu1, Yanxin Luo2,3, Hui Peng4, Liang Kang4, Meijin Huang4, Shuangling Luo4, Wenhao Chen4, Zihuan Yang5, Jianping Wang6,7.   

Abstract

This study aimed to assess the association between postoperative body temperature and prognosis in patients with rectal cancer. Five hundred and seven patients with stage I to III rectal cancers were enrolled in the current study. Basal body temperature (BBT, measured at 6 am) and maximal body temperature (MBT) on each day after surgery were analyzed retrospectively. Patients were divided into two equal groups according to the median of BBT and MBT at each day. The primary end points were disease-free survival (DFS) and overall survival (OS). The univariate and multivariate analyses showed that patients with low D0-MBT (<37.4 °C) had lower 3-year DFS [adjusted hazard ratio (HR) 1.56 (95 % CI 1.08-2.24, P = 0.017)] as well as OS [adjusted HR 1.72 (95 % CI 1.05-2.82, P = 0.032)] rate as compared to those with high D0-MBT (>37.4 °C). In the subset of 318 patients with T3 stage tumor and the subgroup of 458 patients without blood transfusion as well, low D0-MBT continues to be an independent predictor of DFS/OS with an adjusted HR equal to 1.48 (95 % CI 1.02-2.24, P = 0.046)/1.68 (95 % CI 1.04-2.99, P = 0.048) and 1.45 (95 % CI 1.02-2.13, P = 0.048)/1.59 (95 % CI 1.01-2.74, P = 0.049), respectively. In addition, we found that patients have higher risk of 1-year recurrence if those were exhibiting low preoperative BBT (<36.6 °C) (17 vs. 10 %, P = 0.034). Low body temperature (D0-MBT < 37.4 °C) after surgery was an independent predictor of poor survival outcomes in patients with rectal cancer.

Entities:  

Keywords:  Body temperature; Rectal cancer; Risk factor; Survival

Mesh:

Year:  2015        PMID: 25976505     DOI: 10.1007/s13277-015-3535-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  31 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009.

Authors:  Myung Mi Cho; John W Morgan; Raymond Knutsen; Keiji Oda; David Shavlik; Synnove Knutsen; Kevork Kazanjian
Journal:  Dis Colon Rectum       Date:  2013-12       Impact factor: 4.585

3.  Are postoperative fever and/or septic complications prognostic factors in colorectal cancer resected for cure?

Authors:  C Fucini; L Bandettini; M D'Elia; F Filipponi; A Herd-Smith
Journal:  Dis Colon Rectum       Date:  1985-02       Impact factor: 4.585

4.  Blood transfusion and recurrence rates in colonic malignancy.

Authors:  W J Hodgson; A B Lowenfels
Journal:  Lancet       Date:  1982-11-06       Impact factor: 79.321

5.  Clinical outcomes after surgical resection of colorectal cancer in 1,294 patients.

Authors:  Yanxin Luo; Ji Cui; Chuangqi Chen; Shunxin Song; Meijin Huang; Junsheng Peng; Ping Lan; Yihua Huang; Lei Wang; Jianping Wang
Journal:  Hepatogastroenterology       Date:  2012 Jul-Aug

6.  Hypothermic microenvironment plays a key role in tumor immune subversion.

Authors:  Gangjun Du; Yinghui Liu; Jiahuan Li; Weijie Liu; Yingying Wang; Hong Li
Journal:  Int Immunopharmacol       Date:  2013-07-03       Impact factor: 4.932

7.  Changes in the plasma levels of cytokines/chemokines for predicting the response to chemoradiation therapy in rectal cancer patients.

Authors:  Noriko Tada; Nelson H Tsuno; Kazushige Kawai; Koji Murono; Takako Nirei; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  Oncol Rep       Date:  2013-11-19       Impact factor: 3.906

8.  BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.

Authors:  Matthew F Kalady; Kathryn L Dejulius; Julian A Sanchez; Awad Jarrar; Xiuli Liu; Elena Manilich; Marek Skacel; James M Church
Journal:  Dis Colon Rectum       Date:  2012-02       Impact factor: 4.585

9.  Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study.

Authors:  C Tiselius; U Gunnarsson; K Smedh; B Glimelius; L Påhlman
Journal:  Ann Oncol       Date:  2012-08-16       Impact factor: 32.976

Review 10.  Hyperthermia on immune regulation: a temperature's story.

Authors:  Hua-Gang Zhang; Keyur Mehta; Patrice Cohen; Chandan Guha
Journal:  Cancer Lett       Date:  2008-07-01       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.